Skip to main content

Peer Review reports

From: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1

Original Submission
12 Apr 2018 Submitted Original manuscript
10 May 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 2
10 May 2018 Submitted Manuscript version 2
21 Jun 2018 Reviewed Reviewer Report - Elba Susana Vazquez
9 Jul 2018 Reviewed Reviewer Report - Yasuyoshi Miyata
10 Jul 2018 Reviewed Reviewer Report - Cristina Rodríguez-Padilla
13 Jul 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 3
13 Jul 2018 Submitted Manuscript version 3
16 Jul 2018 Reviewed Reviewer Report - Elba Susana Vazquez
31 Jul 2018 Reviewed Reviewer Report - Yasuyoshi Miyata
18 Aug 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 4
18 Aug 2018 Submitted Manuscript version 4
1 Oct 2018 Reviewed Reviewer Report - Elba Susana Vazquez
3 Oct 2018 Author responded Author comments - Yang Jiao
Resubmission - Version 5
3 Oct 2018 Submitted Manuscript version 5
4 Oct 2018 Reviewed Reviewer Report - Elba Susana Vazquez
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
12 Oct 2018 Editorially accepted
26 Oct 2018 Article published 10.1186/s12885-018-4946-9

You can find further information about peer review here.

Back to article page